Common Sleeping Pill May Reduce Build-Up of Alzheimer's Proteins, Study Finds

United States News News

Common Sleeping Pill May Reduce Build-Up of Alzheimer's Proteins, Study Finds
United States Latest News,United States Headlines
  • 📰 ScienceAlert
  • ⏱ Reading Time:
  • 27 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 68%

There's still so much we don't know about Alzheimer's disease, but the link between poor sleep and worsening disease is one that researchers are exploring with gusto.

Though only short and involving a small group of healthy adults, the study is an interesting demonstration of the link between sleep and the molecular markers of Alzheimer's disease.

While sleeping pills may help in that regard,"it would be premature for people who are worried about developing Alzheimer's to interpret it as a reason to start taking suvorexant every night,"neurologist Brendan Lucey, of Washington University's Sleep Medicine Center, who led the research. In their latest study, Lucey and colleagues wanted to see if improving sleep with the aid of sleeping pills could lower levels of tau and amyloid-beta in the cerebrospinal fluid that bathes the brain and spinal cord.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ScienceAlert /  🏆 63. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Brazil Burger King brand owner's shareholders reject poison pill in win for Mubadala By ReutersBrazil Burger King brand owner's shareholders reject poison pill in win for Mubadala By ReutersBrazil Burger King brand owner's shareholders reject poison pill in win for Mubadala
Read more »

Educational attainment protects against a genetic risk factor for Alzheimer's diseaseEducational attainment protects against a genetic risk factor for Alzheimer's diseaseA new study further illustrates that when it comes to risk of Alzheimer's disease, even genetically determined forms of the disease, genetics is only one piece of the puzzle. Researchers investigated the influence of genetics and educational attainment on cognitive decline by studying data from 675 people who carry a mutation that predisposes them to early onset Alzheimer's disease. Carriers of this mutation -- known as PSEN1 E280A -- have a median age of 49 for onset of dementia. The team found that among carriers who also carried a second mutation that puts them at heightened risk -- APOE e4 -- had an accelerated age of onset of cognitive decline. Among carriers who had an APOE e2 mutation -- known to be protective -- age of onset was delayed. The team also assessed the effect of educational attainment on cognitive function among PSEN1 E280A mutation carriers, including those who carried different APOE genotypes. They found that higher educational attainment -- that is, more years of education -- was associated with preserved cognitive ability particularly for those at highest genetic risk.
Read more »

New blood test gives very high accuracy to screen for Alzheimer's diseaseNew blood test gives very high accuracy to screen for Alzheimer's diseaseA new blood test called p-tau217 shows promise as an Alzheimer's disease biomarker, and when used in a two-step workflow very high accuracy to either identify or exclude brain amyloidosis, the most important and earliest pathology.
Read more »

Nationwide study determining if FDA-approved drug can help prevent Alzheimer's diseaseNationwide study determining if FDA-approved drug can help prevent Alzheimer's diseaseA nationwide study, now enrolling in Chicago, is examining whether a drug that is FDA-approved to treat Alzheimer’s disease can prevent the neurodegenerative disease.
Read more »

Brazil Burger King brand owner's shareholders reject poison pill in win for MubadalaBrazil Burger King brand owner's shareholders reject poison pill in win for MubadalaZamp , the owner of the Burger King brand in Brazil, said on Tuesday its shareholders rejected a proposal to include a poison pill in its internal bylaws, a win for Abu Dhabi state investor Mubadala which is building a large stake in the firm.
Read more »

Completely sober Brook Park man sleeping on tree lawn: Parma Heights Police BlotterCompletely sober Brook Park man sleeping on tree lawn: Parma Heights Police BlotterIn this week’s Parma Heights Police Blotter, a concerned passerby called police after seeing a man laying down on a Big Creek Parkway tree lawn.
Read more »



Render Time: 2025-02-22 02:27:46